APO Research
Talk to an analyst

APO RESEARCH · REPORT

Neuroscience

neurological disorders and the essence of human/animal behaviors and cognition. The key question of neuroscience is, as a branch of biology, to understand human neural activities, including learning, memory, attention, awareness, language, thinking and decision making, etc. As a branch of medicine, neuroscience addresses basic issues underlying neuropsychiatric disorders and interventions.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

neurological disorders and the essence of human/animal behaviors and cognition. The key question of neuroscience is, as a branch of biology, to understand human neural activities, including learning, memory, attention, awareness, language, thinking and decision making, etc. As a branch of medicine, neuroscience addresses basic issues underlying neuropsychiatric disorders and interventions.

Selected research

Market Analysis & Forecast

Global Neuroscience Market Analysis and Forecast 2026-2032

31 December 2025192 pages

Choose your research edition.

Industry ResearchNeuroscience Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Neuroscience Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Neuroscience Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neuroscience Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Neuroscience Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

neurological disorders and the essence of human/animal behaviors and cognition. The key question of neuroscience is, as a branch of biology, to understand human neural activities, including learning, memory, attention, awareness, language, thinking and decision making, etc. As a branch of medicine, neuroscience addresses basic issues underlying neuropsychiatric disorders and interventions.

Global neuroscience main manufactuers include Siemens Healthineers, GE Healthcare, etc. The top 3 companies hold a share about 17%. Americas is the largest market of neuroscience, with a share about 40%, followed by Europe and Asia-Pacific.

Report Includes

Read the full market overview

This report presents an overview of global market for Neuroscience, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Neuroscience, also provides the revenue of main regions and countries. Of the upcoming market potential for Neuroscience, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Neuroscience revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Neuroscience market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Neuroscience revenue, projected growth trends, production technology, application and end-user industry.

Neuroscience Segment by Company

Siemens Healthineers

GE Healthcare

Philips

Canon

Hitachi

Medtronic

Leica Microsystems

Zeiss

Nikon

JEOL Ltd

Natus Medical

Nihon Kohden

NeuroPace Inc

Shimadzu Corporation

Compumedics

Neuroscience Segment by Type

Instrument and Consumables

Software

Services

Neuroscience Segment by Application

Academic Institutes

Hospital

Research Institutes

Others

Neuroscience Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neuroscience market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neuroscience and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neuroscience.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Neuroscience in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Neuroscience company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Neuroscience revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Neuroscience Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Instrument and Consumables Major Player Table 3. Software Major Player Table 4. Services Major Player Table 5. Global Neuroscience Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Academic Institutes Major Player Table 7. Hospital Major Player Table 8. Research Institutes Major Player Table 9. Others Major Player Table 10. Neuroscience Industry Trends Table 11. Neuroscience Industry Drivers Table 12. Neuroscience Industry Opportunities and Challenges Table 13. Neuroscience Industry Restraints Table 14. Global Neuroscience Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Neuroscience Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Neuroscience Market Share by Region (2021-2026) Table 17. Global Neuroscience Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Neuroscience Market Share by Region (2027-2032) Table 19. Global Neuroscience Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Neuroscience Revenue Market Share by Players (2021-2026) Table 21. Global Neuroscience Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Neuroscience Key Players Headquarters & Area Served Table 23. Global Neuroscience Players, Product Type & Application Table 24. Global Neuroscience Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Neuroscience by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Neuroscience Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Neuroscience Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Neuroscience Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Neuroscience Revenue Market Share by Type (2021-2026) Table 31. Global Neuroscience Revenue Market Share by Type (2027-2032) Table 32. Global Neuroscience Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Neuroscience Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Neuroscience Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Neuroscience Revenue Market Share by Application (2021-2026) Table 36. Global Neuroscience Revenue Market Share by Application (2027-2032) Table 37. Siemens Healthineers Company Information Table 38. Siemens Healthineers Business Overview Table 39. Siemens Healthineers Neuroscience Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Siemens Healthineers Neuroscience Product Portfolio Table 41. Siemens Healthineers Recent Development Table 42. GE Healthcare Company Information Table 43. GE Healthcare Business Overview Table 44. GE Healthcare Neuroscience Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. GE Healthcare Neuroscience Product Portfolio Table 46. GE Healthcare Recent Development Table 47. Philips Company Information Table 48. Philips Business Overview Table 49. Philips Neuroscience Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Philips Neuroscience Product Portfolio Table 51. Philips Recent Development Table 52. Canon Company Information Table 53. Canon Business Overview Table 54. Canon Neuroscience Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Canon Neuroscience Product Portfolio Table 56. Canon Recent Development Table 57. Hitachi Company Information Table 58. Hitachi Business Overview Table 59. Hitachi Neuroscience Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Hitachi Neuroscience Product Portfolio Table 61. Hitachi Recent Development Table 62. Medtronic Company Information Table 63. Medtronic Business Overview Table 64. Medtronic Neuroscience Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Medtronic Neuroscience Product Portfolio Table 66. Medtronic Recent Development Table 67. Leica Microsystems Company Information Table 68. Leica Microsystems Business Overview Table 69. Leica Microsystems Neuroscience Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Leica Microsystems Neuroscience Product Portfolio Table 71. Leica Microsystems Recent Development Table 72. Zeiss Company Information Table 73. Zeiss Business Overview Table 74. Zeiss Neuroscience Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Zeiss Neuroscience Product Portfolio Table 76. Zeiss Recent Development Table 77. Nikon Company Information Table 78. Nikon Business Overview Table 79. Nikon Neuroscience Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Nikon Neuroscience Product Portfolio Table 81. Nikon Recent Development Table 82. JEOL Ltd Company Information Table 83. JEOL Ltd Business Overview Table 84. JEOL Ltd Neuroscience Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. JEOL Ltd Neuroscience Product Portfolio Table 86. JEOL Ltd Recent Development Table 87. Natus Medical Company Information Table 88. Natus Medical Business Overview Table 89. Natus Medical Neuroscience Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 90. Natus Medical Neuroscience Product Portfolio Table 91. Natus Medical Recent Development Table 92. Nihon Kohden Company Information Table 93. Nihon Kohden Business Overview Table 94. Nihon Kohden Neuroscience Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 95. Nihon Kohden Neuroscience Product Portfolio Table 96. Nihon Kohden Recent Development Table 97. NeuroPace Inc Company Information Table 98. NeuroPace Inc Business Overview Table 99. NeuroPace Inc Neuroscience Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 100. NeuroPace Inc Neuroscience Product Portfolio Table 101. NeuroPace Inc Recent Development Table 102. Shimadzu Corporation Company Information Table 103. Shimadzu Corporation Business Overview Table 104. Shimadzu Corporation Neuroscience Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 105. Shimadzu Corporation Neuroscience Product Portfolio Table 106. Shimadzu Corporation Recent Development Table 107. Compumedics Company Information Table 108. Compumedics Business Overview Table 109. Compumedics Neuroscience Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2021-2026) Table 110. Compumedics Neuroscience Product Portfolio Table 111. Compumedics Recent Development Table 112. North America Neuroscience Revenue by Type (2021-2026) & (US$ Million) Table 113. North America Neuroscience Revenue by Type (2027-2032) & (US$ Million) Table 114. North America Neuroscience Revenue by Application (2021-2026) & (US$ Million) Table 115. North America Neuroscience Revenue by Application (2027-2032) & (US$ Million) Table 116. North America Neuroscience Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. North America Neuroscience Revenue by Country (2021-2026) & (US$ Million) Table 118. North America Neuroscience Revenue by Country (US$ Million) & (2027-2032) Table 119. Europe Neuroscience Revenue by Type (2021-2026) & (US$ Million) Table 120. Europe Neuroscience Revenue by Type (2027-2032) & (US$ Million) Table 121. Europe Neuroscience Revenue by Application (2021-2026) & (US$ Million) Table 122. Europe Neuroscience Revenue by Application (2027-2032) & (US$ Million) Table 123. Europe Neuroscience Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. Europe Neuroscience Revenue by Country (2021-2026) & (US$ Million) Table 125. Europe Neuroscience Revenue by Country (US$ Million) & (2027-2032) Table 126. China Neuroscience Revenue by Type (2021-2026) & (US$ Million) Table 127. China Neuroscience Revenue by Type (2027-2032) & (US$ Million) Table 128. China Neuroscience Revenue by Application (2021-2026) & (US$ Million) Table 129. China Neuroscience Revenue by Application (2027-2032) & (US$ Million) Table 130. Asia Neuroscience Revenue by Type (2021-2026) & (US$ Million) Table 131. Asia Neuroscience Revenue by Type (2027-2032) & (US$ Million) Table 132. Asia Neuroscience Revenue by Application (2021-2026) & (US$ Million) Table 133. Asia Neuroscience Revenue by Application (2027-2032) & (US$ Million) Table 134. Asia Neuroscience Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 135. Asia Neuroscience Revenue by Region (US$ Million) & (2021-2026) Table 136. Asia Neuroscience Revenue by Region (US$ Million) & (2027-2032) Table 137. SAMEA Neuroscience Revenue by Type (2021-2026) & (US$ Million) Table 138. SAMEA Neuroscience Revenue by Type (2027-2032) & (US$ Million) Table 139. SAMEA Neuroscience Revenue by Application (2021-2026) & (US$ Million) Table 140. SAMEA Neuroscience Revenue by Application (2027-2032) & (US$ Million) Table 141. SAMEA Neuroscience Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. SAMEA Neuroscience Revenue by Country (2021-2026) & (US$ Million) Table 143. SAMEA Neuroscience Revenue by Country (US$ Million) & (2027-2032) Table 144. Research Programs/Design for This Report Table 145. Authors List of This Report Table 146. Secondary Sources Table 147. Primary Sources List of Figures Figure 1. Neuroscience Image Figure 2. Global Neuroscience Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neuroscience Market Size Share 2021 VS 2025 VS 2032 Figure 4. Instrument and Consumables Image Figure 5. Software Image Figure 6. Services Image Figure 7. Global Neuroscience Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Neuroscience Market Size Share 2021 VS 2025 VS 2032 Figure 9. Academic Institutes Image Figure 10. Hospital Image Figure 11. Research Institutes Image Figure 12. Others Image Figure 13. Global Neuroscience Market Size (US$ Million) & (2021-2032) Figure 14. Global Neuroscience Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Neuroscience Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Neuroscience Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Neuroscience Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Neuroscience Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Neuroscience Revenue Market Share by Type (2021-2032) Figure 21. Global Neuroscience Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Neuroscience Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Neuroscience Revenue Market Share by Application (2021-2032) Figure 24. North America Neuroscience Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Neuroscience Revenue Share by Type (2021-2032) Figure 26. North America Neuroscience Revenue Share by Application (2021-2032) Figure 27. North America Neuroscience Revenue Share by Country (2021-2032) Figure 28. United States Neuroscience Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Neuroscience Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Neuroscience Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Neuroscience Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Neuroscience Revenue Share by Type (2021-2032) Figure 33. Europe Neuroscience Revenue Share by Application (2021-2032) Figure 34. Europe Neuroscience Revenue Share by Country (2021-2032) Figure 35. Germany Neuroscience Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Neuroscience Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Neuroscience Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Neuroscience Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Neuroscience Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Neuroscience Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Neuroscience Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Neuroscience Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Neuroscience Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Neuroscience Revenue Share by Type (2021-2032) Figure 45. China Neuroscience Revenue Share by Application (2021-2032) Figure 46. Asia Neuroscience Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Neuroscience Revenue Share by Type (2021-2032) Figure 48. Asia Neuroscience Revenue Share by Application (2021-2032) Figure 49. Asia Neuroscience Revenue Share by Region (2021-2032) Figure 50. Japan Neuroscience Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Neuroscience Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Neuroscience Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Neuroscience Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Neuroscience Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Neuroscience Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Neuroscience Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Neuroscience Revenue Share by Type (2021-2032) Figure 58. SAMEA Neuroscience Revenue Share by Application (2021-2032) Figure 59. SAMEA Neuroscience Revenue Share by Country (2021-2032) Figure 60. Brazil Neuroscience Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Neuroscience Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Neuroscience Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Neuroscience Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Neuroscience Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Neuroscience Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Neuroscience Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Neuroscience Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Neuroscience Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Neuroscience Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Neuroscience Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Instrument and Consumables
  • Software
  • Services
Applications
  • Academic Institutes
  • Hospital
  • Research Institutes
  • Others
Companies covered
  • Siemens Healthineers
  • GE Healthcare
  • Philips
  • Canon
  • Hitachi
  • Medtronic
  • Leica Microsystems
  • Zeiss
  • Nikon
  • JEOL Ltd
  • Natus Medical
  • Nihon Kohden
  • NeuroPace Inc
  • Shimadzu Corporation
  • Compumedics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Neuroscience Market by Type
  3. 1.2.1 Global Neuroscience Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Instrument and Consumables
  5. 1.2.3 Software
  6. 1.2.4 Services
  7. 1.3 Neuroscience Market by Application
  8. 1.3.1 Global Neuroscience Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Academic Institutes
  10. 1.3.3 Hospital
  11. 1.3.4 Research Institutes
  12. 1.3.5 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Neuroscience Market Dynamics
  1. 2.1 Neuroscience Industry Trends
  2. 2.2 Neuroscience Industry Drivers
  3. 2.3 Neuroscience Industry Opportunities and Challenges
  4. 2.4 Neuroscience Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Neuroscience Market Perspective (2021-2032)
  2. 3.2 Global Neuroscience Growth Trends by Region
  3. 3.2.1 Global Neuroscience Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Neuroscience Market Size by Region (2021-2026)
  5. 3.2.3 Global Neuroscience Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Neuroscience Revenue by Players
  2. 4.1.1 Global Neuroscience Revenue by Players (2021-2026)
  3. 4.1.2 Global Neuroscience Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Neuroscience Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Neuroscience Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Neuroscience Key Players Headquarters & Area Served
  7. 4.4 Global Neuroscience Players, Product Type & Application
  8. 4.5 Global Neuroscience Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Neuroscience Market CR5 and HHI
  11. 4.6.3 2025 Neuroscience Tier 1, Tier 2, and Tier 3
5 Neuroscience Market Size by Type
  1. 5.1 Global Neuroscience Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Neuroscience Revenue by Type (2021-2032)
  3. 5.3 Global Neuroscience Revenue Market Share by Type (2021-2032)
6 Neuroscience Market Size by Application
  1. 6.1 Global Neuroscience Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Neuroscience Revenue by Application (2021-2032)
  3. 6.3 Global Neuroscience Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Siemens Healthineers
  2. 7.1.1 Siemens Healthineers Company Information
  3. 7.1.2 Siemens Healthineers Business Overview
  4. 7.1.3 Siemens Healthineers Neuroscience Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Siemens Healthineers Neuroscience Product Portfolio
  6. 7.1.5 Siemens Healthineers Recent Developments
  7. 7.2 GE Healthcare
  8. 7.2.1 GE Healthcare Company Information
  9. 7.2.2 GE Healthcare Business Overview
  10. 7.2.3 GE Healthcare Neuroscience Revenue and Gross Margin (2021-2026)
  11. 7.2.4 GE Healthcare Neuroscience Product Portfolio
  12. 7.2.5 GE Healthcare Recent Developments
  13. 7.3 Philips
  14. 7.3.1 Philips Company Information
  15. 7.3.2 Philips Business Overview
  16. 7.3.3 Philips Neuroscience Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Philips Neuroscience Product Portfolio
  18. 7.3.5 Philips Recent Developments
  19. 7.4 Canon
  20. 7.4.1 Canon Company Information
  21. 7.4.2 Canon Business Overview
  22. 7.4.3 Canon Neuroscience Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Canon Neuroscience Product Portfolio
  24. 7.4.5 Canon Recent Developments
  25. 7.5 Hitachi
  26. 7.5.1 Hitachi Company Information
  27. 7.5.2 Hitachi Business Overview
  28. 7.5.3 Hitachi Neuroscience Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Hitachi Neuroscience Product Portfolio
  30. 7.5.5 Hitachi Recent Developments
  31. 7.6 Medtronic
  32. 7.6.1 Medtronic Company Information
  33. 7.6.2 Medtronic Business Overview
  34. 7.6.3 Medtronic Neuroscience Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Medtronic Neuroscience Product Portfolio
  36. 7.6.5 Medtronic Recent Developments
  37. 7.7 Leica Microsystems
  38. 7.7.1 Leica Microsystems Company Information
  39. 7.7.2 Leica Microsystems Business Overview
  40. 7.7.3 Leica Microsystems Neuroscience Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Leica Microsystems Neuroscience Product Portfolio
  42. 7.7.5 Leica Microsystems Recent Developments
  43. 7.8 Zeiss
  44. 7.8.1 Zeiss Company Information
  45. 7.8.2 Zeiss Business Overview
  46. 7.8.3 Zeiss Neuroscience Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Zeiss Neuroscience Product Portfolio
  48. 7.8.5 Zeiss Recent Developments
  49. 7.9 Nikon
  50. 7.9.1 Nikon Company Information
  51. 7.9.2 Nikon Business Overview
  52. 7.9.3 Nikon Neuroscience Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Nikon Neuroscience Product Portfolio
  54. 7.9.5 Nikon Recent Developments
  55. 7.10 JEOL Ltd
  56. 7.10.1 JEOL Ltd Company Information
  57. 7.10.2 JEOL Ltd Business Overview
  58. 7.10.3 JEOL Ltd Neuroscience Revenue and Gross Margin (2021-2026)
  59. 7.10.4 JEOL Ltd Neuroscience Product Portfolio
  60. 7.10.5 JEOL Ltd Recent Developments
  61. 7.11 Natus Medical
  62. 7.11.1 Natus Medical Company Information
  63. 7.11.2 Natus Medical Business Overview
  64. 7.11.3 Natus Medical Neuroscience Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Natus Medical Neuroscience Product Portfolio
  66. 7.11.5 Natus Medical Recent Developments
  67. 7.12 Nihon Kohden
  68. 7.12.1 Nihon Kohden Company Information
  69. 7.12.2 Nihon Kohden Business Overview
  70. 7.12.3 Nihon Kohden Neuroscience Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Nihon Kohden Neuroscience Product Portfolio
  72. 7.12.5 Nihon Kohden Recent Developments
  73. 7.13 NeuroPace Inc
  74. 7.13.1 NeuroPace Inc Company Information
  75. 7.13.2 NeuroPace Inc Business Overview
  76. 7.13.3 NeuroPace Inc Neuroscience Revenue and Gross Margin (2021-2026)
  77. 7.13.4 NeuroPace Inc Neuroscience Product Portfolio
  78. 7.13.5 NeuroPace Inc Recent Developments
  79. 7.14 Shimadzu Corporation
  80. 7.14.1 Shimadzu Corporation Company Information
  81. 7.14.2 Shimadzu Corporation Business Overview
  82. 7.14.3 Shimadzu Corporation Neuroscience Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Shimadzu Corporation Neuroscience Product Portfolio
  84. 7.14.5 Shimadzu Corporation Recent Developments
  85. 7.15 Compumedics
  86. 7.15.1 Compumedics Company Information
  87. 7.15.2 Compumedics Business Overview
  88. 7.15.3 Compumedics Neuroscience Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Compumedics Neuroscience Product Portfolio
  90. 7.15.5 Compumedics Recent Developments
8 North America
  1. 8.1 North America Neuroscience Revenue (2021-2032)
  2. 8.2 North America Neuroscience Revenue by Type (2021-2032)
  3. 8.2.1 North America Neuroscience Revenue by Type (2021-2026)
  4. 8.2.2 North America Neuroscience Revenue by Type (2027-2032)
  5. 8.3 North America Neuroscience Revenue Share by Type (2021-2032)
  6. 8.4 North America Neuroscience Revenue by Application (2021-2032)
  7. 8.4.1 North America Neuroscience Revenue by Application (2021-2026)
  8. 8.4.2 North America Neuroscience Revenue by Application (2027-2032)
  9. 8.5 North America Neuroscience Revenue Share by Application (2021-2032)
  10. 8.6 North America Neuroscience Revenue by Country
  11. 8.6.1 North America Neuroscience Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Neuroscience Revenue by Country (2021-2026)
  13. 8.6.3 North America Neuroscience Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Neuroscience Revenue (2021-2032)
  2. 9.2 Europe Neuroscience Revenue by Type (2021-2032)
  3. 9.2.1 Europe Neuroscience Revenue by Type (2021-2026)
  4. 9.2.2 Europe Neuroscience Revenue by Type (2027-2032)
  5. 9.3 Europe Neuroscience Revenue Share by Type (2021-2032)
  6. 9.4 Europe Neuroscience Revenue by Application (2021-2032)
  7. 9.4.1 Europe Neuroscience Revenue by Application (2021-2026)
  8. 9.4.2 Europe Neuroscience Revenue by Application (2027-2032)
  9. 9.5 Europe Neuroscience Revenue Share by Application (2021-2032)
  10. 9.6 Europe Neuroscience Revenue by Country
  11. 9.6.1 Europe Neuroscience Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Neuroscience Revenue by Country (2021-2026)
  13. 9.6.3 Europe Neuroscience Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Neuroscience Revenue (2021-2032)
  2. 10.2 China Neuroscience Revenue by Type (2021-2032)
  3. 10.2.1 China Neuroscience Revenue by Type (2021-2026)
  4. 10.2.2 China Neuroscience Revenue by Type (2027-2032)
  5. 10.3 China Neuroscience Revenue Share by Type (2021-2032)
  6. 10.4 China Neuroscience Revenue by Application (2021-2032)
  7. 10.4.1 China Neuroscience Revenue by Application (2021-2026)
  8. 10.4.2 China Neuroscience Revenue by Application (2027-2032)
  9. 10.5 China Neuroscience Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Neuroscience Revenue (2021-2032)
  2. 11.2 Asia Neuroscience Revenue by Type (2021-2032)
  3. 11.2.1 Asia Neuroscience Revenue by Type (2021-2026)
  4. 11.2.2 Asia Neuroscience Revenue by Type (2027-2032)
  5. 11.3 Asia Neuroscience Revenue Share by Type (2021-2032)
  6. 11.4 Asia Neuroscience Revenue by Application (2021-2032)
  7. 11.4.1 Asia Neuroscience Revenue by Application (2021-2026)
  8. 11.4.2 Asia Neuroscience Revenue by Application (2027-2032)
  9. 11.5 Asia Neuroscience Revenue Share by Application (2021-2032)
  10. 11.6 Asia Neuroscience Revenue by Country
  11. 11.6.1 Asia Neuroscience Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Neuroscience Revenue by Country (2021-2026)
  13. 11.6.3 Asia Neuroscience Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Neuroscience Revenue (2021-2032)
  2. 12.2 SAMEA Neuroscience Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Neuroscience Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Neuroscience Revenue by Type (2027-2032)
  5. 12.3 SAMEA Neuroscience Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Neuroscience Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Neuroscience Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Neuroscience Revenue by Application (2027-2032)
  9. 12.5 SAMEA Neuroscience Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Neuroscience Revenue by Country
  11. 12.6.1 SAMEA Neuroscience Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Neuroscience Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Neuroscience Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst